Completed Cells, Biochemistry & Physiology Genetics & Molecular Biology

Core support for the Wellcome Trust Cancer Research UK Gurdon Institute.

In plain English

AI plain-English summary

The Gurdon Institute in Cambridge is asking for continued core funding to keep its labs running, its microscopes focused, and its mouse colony healthy. This matters because the Institute studies how a single fertilised egg builds a complex animal—a process called development. When that process goes wrong, the result is often cancer. By understanding the normal rules of cell growth, division, and shape-shifting, researchers can pinpoint exactly where cancer breaks those rules. The Institute’s work sits at the intersection of developmental biology and cancer research, aiming to explain fundamental mechanisms rather than test a specific drug or therapy. If the funding continues, the Institute will upgrade its imaging and sequencing equipment and add new facilities for mass spectrometry and high-content screening. These tools allow scientists to scan thousands of genes or proteins at once, revealing patterns that single experiments miss. The research is fundamental science—it will not produce a new treatment next year. But past discoveries in developmental biology have led to breakthroughs in stem cell medicine, regenerative therapies, and targeted cancer drugs. A deeper understanding of how cells decide their fate could eventually change how we diagnose or treat cancers that currently resist therapy.

View original technical description
This application requests the continuation of core support to the Wellcome Trust/Cancer Research UK Gurdon Institute, which is an integral part of the University of Cambridge. The aim of the Institute is to contribute to an understanding of normal animal development, including the processes of cell differentiation, proliferation and morphogenesis, and to explain how cancers arise when these processes go wrong. The Institute sets out to achieve these objectives by recruiting excellent scientists and providing them with the best possible environment and facilities for their work. This is made possible by our core funding, which provides technical, administrative and secretarial support to our research groups, as well as expert assistance in bioinformatics, imaging and computing. Core support also ensures that our researchers have access to state of the art facilities, and we are requesting funding for advanced microscopy and high throughput sequencing equipment, and continuing support fo r our mouse facility. Our major goal for the next quinquennium is to produce world class research at the interface between developmental biology and cancer. To achieve this, we will increasingly use genome-wide approaches and quantitative proteomics, and we therefore plan to establish facilities for high throughput sequencing, high content screening, and mass spectroscopy.

View the original record at the funder ↗

Researchers

Daniel St Johnston (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Cellular Medicine at the Cambridge Institute for Medical Research.
Core funding for Wellcome Trust / Cancer Research UK Gurdon Institute
Core funding renewal for the Wellcome Trust Centre for Cell Biology .
Wellcome Trust Technology Platform
Establishing The Edinburgh Super-Resolution Imaging Consortium (ESRIC)

Original classification

Wellcome Trust Centre

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.